Abstract
The objective of this study was to evaluate the performance of CHROMagar Acinetobacter when compared to sheep blood agar, MacConkey agar and MacConkey agar with 6 μg/ml of imipenem for the detection of A. baumannii in surveillance cultures of hospitalized patients. We utilized peri-anal swabs and sputum samples from patients admitted to the University of Maryland Medical Center ICUs from December 7 through December 21, 2009. Samples were plated onto four media in the following order: (1) 5% sheep blood agar (SBA), (2) MacConkey agar, (3) MacConkey agar with 6 μg/ml of imipenem, and (4) CHROMagar Acinetobacter (CHROMagar). SBA was the gold standard to which all media was compared. There were 165 samples collected during the study period. SBA and CHROMagar detected 18 of 18 (100%) Acinetobacter and 11 of 11 (100%) MDR-A. baumannii. MacConkey agar detected 16 of 18 (89%) Acinetobacter and 10 of 11 (91%) MDR- A. baumannii while MacConkey agar with 6 μg/ml imipenem detected 9 of 11 (82%) MDR-A. baumannii. CHROMagar did not differentiate MDR- A. baumannii from non-MDR-A. baumannii. CHROMagar may be useful for rapid detection of patients with MDR-A. baumannii if improved upon to better select for MDR-A. baumannii.
Similar content being viewed by others
References
Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A (2007) Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13(1):97–103
Playford EG, Craig JC, Iredell JR (2007) Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 65(3):204–211. doi:10.1016/j.jhin.2006.11.010
Kwon KT, Oh WS, Song JH, Chang HH, Jung SI, Kim SW, Ryu SY, Heo ST, Jung DS, Rhee JY, Shin SY, Ko KS, Peck KR, Lee NY (2007) Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 59(3):525–530. doi:10.1093/jac/dkl499
Munoz-Price LS, Weinstein RA (2008) Acinetobacter infection. N Engl J Med 358(12):1271–1281. doi:10.1056/NEJMra070741
Urban C, Meyer KS, Mariano N, Rahal JJ, Flamm R, Rasmussen BA, Bush K (1994) Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 38(2):392–395
Kohlenberg A, Brummer S, Higgins PG, Sohr D, Piening BC, de Grahl C, Halle E, Ruden H, Seifert H (2009) Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J Med Microbiol 58(Pt 11):1499–1507. doi:10.1099/jmm.0.012302-0
Fontana C, Favaro M, Minelli S, Bossa MC, Testore GP, Leonardis F, Natoli S, Favalli C (2008) Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates. BMC Infect Dis 8;8:79. doi:10.1186/1471-2334-8-79
Lolans K, Rice TW, Munoz-Price LS, Quinn JP (2006) Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 50(9):2941–2945. doi:10.1128/AAC.00116-06
Heritier C, Dubouix A, Poirel L, Marty N, Nordmann P (2005) A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J Antimicrob Chemother 55(1):115–118. doi:10.1093/jac/dkh500
Maragakis LL, Cosgrove SE, Song X, Kim D, Rosenbaum P, Ciesla N, Srinivasan A, Ross T, Carroll K, Perl TM (2004) An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 292(24):3006–3011. doi:10.1001/jama.292.24.3006
Melamed R, Greenberg D, Porat N, Karplus M, Zmora E, Golan A, Yagupsky P, Dagan R (2003) Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit. J Hosp Infect 53(1):31–38
Maragakis LL, Tucker MG, Miller RG, Carroll KC, Perl TM (2008) Incidence and prevalence of multidrug-resistant acinetobacter using targeted active surveillance cultures. JAMA 299(21):2513–2514. doi:10.1001/jama.299.21.2513
Wise KA, Tosolini FA (1990) Epidemiological surveillance of Acinetobacter species. J Hosp Infect 16(4):319–329.
Kollef KE, Schramm GE, Wills AR, Reichley RM, Micek ST, Kollef MH (2008) Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 134(2):281–287. doi:10.1378/chest.08-1116
Flayhart D, Hindler JF, Bruckner DA, Hall G, Shrestha RK, Vogel SA, Richter SS, Howard W, Walther R, Carroll KC (2005) Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol 43(11):5536–5540. doi:10.1128/JCM.43.11.5536-5540.2005
Yang HY, Suh JT, Lee HJ (2010) Evaluation of commercial selective agars in screening for methicillin-resistant Staphylococcus aureus. Ann Clin Lab Sci 40(3):252–256.
Stamper PD, Shulder S, Bekalo P, Manandhar D, Ross TL, Speser S, Kingery J, Carroll KC (2010) Evaluation of BBL CHROMagar VanRE for detection of vancomycin-resistant Enterococci in rectal swab specimens. J Clin Microbiol 48(11):4294–4297. doi:10.1128/JCM.01522-10
Saito R, Koyano S, Nagai R, Okamura N, Moriya K, Koike K (2010) Evaluation of a chromogenic agar medium for the detection of extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Lett Appl Microbiol 51(6):704–706.
Huang TD, Bogaerts P, Berhin C, Guisset A, Glupczynski Y (2010) Evaluation of Brilliance ESBL agar, a novel chromogenic medium for detection of extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Clin Microbiol 48(6):2091–2096. doi:10.1128/JCM.02342-09
Randall LP, Kirchner M, Teale CJ, Coldham NG, Liebana E, Clifton-Hadley F (2009) Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains. J Antimicrob Chemother 63(2):302–308. doi:10.1093/jac/dkn485
Panagea T, Galani I, Souli M, Adamou P, Antoniadou A, Giamarellou H (2011) Evaluation of CHROMagar KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures. Int J Antimicrob Agents 37(2):124–128 doi:10.1016/j.ijantimicag.2010.10.010
Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. CLSI
Thom KA, Hsiao WW, Harris AD, Stine OC, Rasko DA, Johnson JK (2010) Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains. Am J Infect Control 38(9):751–753. doi:10.1016/j.ajic.2010.03.005
Morgan DJ, Liang SY, Smith CL, Johnson JK, Harris AD, Furuno JP, Thom KA, Snyder GM, Day HR, Perencevich EN (2010) Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol 31(7):716–721. doi:10.1086/653201
Jawad A, Hawkey PM, Heritage J, Snelling AM (1994) Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton’s agar. J Clin Microbiol 32(10):2353–2358.
Gordon NC, Wareham DW (2009) Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients. J Clin Microbiol 47(7):2249–2251. doi:10.1128/JCM.00634-09
Akers KS, Barsoumian A, Beckius ML, Murray CK, Mende K (2010) CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex. Diagn Microbiol Infect Dis 67(2):209–211. doi:10.1016/j.diagmicrobio.2010.02.004
Wareham DW, Gordon NC (2011) Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii. J Clin Microbiol 47(7):2249–2251. doi:10.1136/jcp.2010.083469
Acknowledgements
CHROMagar (Paris, France) supplied powdered media for the study and supported previous presentation of this data.
Dr. Harris was supported by National Institutes of Health Midcareer Investigator Award 1K24AI079040 and 2R01AI060859-05. Dr. Furuno was supported by National Institutes of Health Career Development Award 1K01AI071015-03 and Agency for Healthcare Research and Quality Contract Number: HHSA290200600020. Dr. Johnson is supported by National Institutes of Health grant 1K12RR023250-03. AO received travel funds to present this data at the 50th ICAAC, Boston, MA, 2010.
Conflict of Interest
The authors declare that they have no conflict of interest to report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ajao, A.O., Robinson, G., Lee, M.S. et al. Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients. Eur J Clin Microbiol Infect Dis 30, 1425–1430 (2011). https://doi.org/10.1007/s10096-011-1237-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-011-1237-7